Aortic Dissection and Acute Aortic Syndromes
Coagulopathy and Bleeding Management for Aortic Dissection Surgery
Publication
, Chapter
Levy, JH; Sniecinski, RM
January 1, 2021
In patients following aortic surgery, the prevention and treatment of bleeding requires a multimodal approach that includes targeting fibrinogen and platelet repletion, the use of anti-fibrinolytic agents, and evaluating surgical sources of bleeding. Prothrombin complex concentrates, and fibrinogen concentrates are becoming increasingly important components of treatment algorithms. With major hemorrhage, specific protocols for massive transfusion in conjunction with pharmacologic agents should be considered. Bleeding management algorithms using viscoelastic testing to guide targeted replacement are being used increasingly in complex cardiac surgical patients.
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Levy, J. H., & Sniecinski, R. M. (2021). Coagulopathy and Bleeding Management for Aortic Dissection Surgery. In Aortic Dissection and Acute Aortic Syndromes (pp. 577–593). https://doi.org/10.1007/978-3-030-66668-2_39
Levy, J. H., and R. M. Sniecinski. “Coagulopathy and Bleeding Management for Aortic Dissection Surgery.” In Aortic Dissection and Acute Aortic Syndromes, 577–93, 2021. https://doi.org/10.1007/978-3-030-66668-2_39.
Levy JH, Sniecinski RM. Coagulopathy and Bleeding Management for Aortic Dissection Surgery. In: Aortic Dissection and Acute Aortic Syndromes. 2021. p. 577–93.
Levy, J. H., and R. M. Sniecinski. “Coagulopathy and Bleeding Management for Aortic Dissection Surgery.” Aortic Dissection and Acute Aortic Syndromes, 2021, pp. 577–93. Scopus, doi:10.1007/978-3-030-66668-2_39.
Levy JH, Sniecinski RM. Coagulopathy and Bleeding Management for Aortic Dissection Surgery. Aortic Dissection and Acute Aortic Syndromes. 2021. p. 577–593.